-
Infection preventionists looking for guidance on discontinuing contact isolation for patients with multidrug-resistant Acinetobacter baumannii (MDR-Ab) remain in a quandary.
-
Like a hurricane downgraded to a tropical depression, H1N1 influenza A has lost its pandemic status and is now just another troublesome flu bug as infection preventionists prepare for the annual outbreak season.
-
In the increasingly litigious arena of infection prevention, juries are interpreting recommendations by the Centers for Disease Control and Prevention (CDC) as "mandated" standards of care.
-
With the Occupational Safety and Health Administration (OSHA) opening preliminary rulemaking on a national infectious disease standard, infection preventionists pondering the end result of the effort may follow the old admonition, "look to California."
-
-
Nasal carriage of mr-cons was prospectively investigated in 291 adults upon hospital admission.
-
Using liquid medium with a commercial air sampler, air was sampled at varying distances from 19 patients admitted to the hospital with Pneumocystis pneumonia. Samples were examined and DNA quantified using a real-time PCR assay targeting the large subunit ribosomal RNA gene.
-
Colistin (Ppolymyxin E) was isolated from bacillus colistinus 60 years ago and, during the 1960s, a new intravenous formulation (Coly-Mycin M Parenteral) became available for use in clinical practice.
-
-
In this issue: Lorcaserin submitted for FDA review, FDA advisory panel votes against phentermine/topiramate, mixed vote on rosiglitazone, advisory panel votes to remove breast cancer indication from bevacizumab labeling, no increase in seizures found with DTaP vaccine, new REMS for quinine.